141 related articles for article (PubMed ID: 30192842)
1. Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.
Schütze M; de Souza Costa D; de Paula JJ; Malloy-Diniz LF; Malamut C; Mamede M; Miranda DM; Brammer M; Romano-Silva MA
PLoS One; 2018; 13(9):e0203520. PubMed ID: 30192842
[TBL] [Abstract][Full Text] [Related]
2. White matter microstructure of patients with neurofibromatosis type 1 and its relation to inhibitory control.
Koini M; Rombouts SARB; Veer IM; Van Buchem MA; Huijbregts SCJ
Brain Imaging Behav; 2017 Dec; 11(6):1731-1740. PubMed ID: 27796732
[TBL] [Abstract][Full Text] [Related]
3. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
Hyman SL; Shores A; North KN
Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in children with neurofibromatosis-1.
Kaplan AM; Chen K; Lawson MA; Wodrich DL; Bonstelle CT; Reiman EM
J Child Neurol; 1997 Nov; 12(8):499-506. PubMed ID: 9430315
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
[TBL] [Abstract][Full Text] [Related]
6. Adaptive functioning in children with neurofibromatosis type 1: relationship to cognition, behavior, and magnetic resonance imaging.
Eby NS; Griffith JL; Gutmann DH; Morris SM
Dev Med Child Neurol; 2019 Aug; 61(8):972-978. PubMed ID: 30659594
[TBL] [Abstract][Full Text] [Related]
7. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A
J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
[TBL] [Abstract][Full Text] [Related]
8. Cerebral glucose metabolism in adults with neurofibromatosis type 1.
Apostolova I; Derlin T; Salamon J; Amthauer H; Granström S; Brenner W; Mautner VF; Buchert R
Brain Res; 2015 Nov; 1625():97-101. PubMed ID: 26335059
[TBL] [Abstract][Full Text] [Related]
9. Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1.
Buchert R; von Borczyskowski D; Wilke F; Gronowsky M; Friedrich RE; Brenner W; Mester J; Clausen M; Mautner VF
Nucl Med Commun; 2008 Jan; 29(1):17-26. PubMed ID: 18049093
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
Chirindel A; Chaudhry M; Blakeley JO; Wahl R
J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities.
Feldmann R; Denecke J; Grenzebach M; Schuierer G; Weglage J
Neurology; 2003 Dec; 61(12):1725-8. PubMed ID: 14694037
[TBL] [Abstract][Full Text] [Related]
12. Auditory temporal processing deficits and language disorders in patients with neurofibromatosis type 1.
Batista PB; Lemos SM; Rodrigues LO; de Rezende NA
J Commun Disord; 2014; 48():18-26. PubMed ID: 24447521
[TBL] [Abstract][Full Text] [Related]
13. Cognitive profile and disorders affecting higher brain functions in paediatric patients with neurofibromatosis type 1.
Vaucheret Paz E; López Ballent A; Puga C; García Basalo MJ; Baliarda F; Ekonen C; Ilari R; Agosta G
Neurologia (Engl Ed); 2019; 34(6):353-359. PubMed ID: 28431841
[TBL] [Abstract][Full Text] [Related]
14. [Neuropsychological performance in neurofibromatosis type 1].
Hernández Del Castillo L; Martínez Bermejo A; Portellano Pérez JA; Tirado Requero P; Garriz Luis A; Velázquez Fragua R
An Pediatr (Barc); 2017 Aug; 87(2):73-77. PubMed ID: 27639957
[TBL] [Abstract][Full Text] [Related]
15. Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults.
Gardener SL; Sohrabi HR; Shen KK; Rainey-Smith SR; Weinborn M; Bates KA; Shah T; Foster JK; Lenzo N; Salvado O; Laske C; Laws SM; Taddei K; Verdile G; Martins RN
J Alzheimers Dis; 2016 Mar; 52(2):661-72. PubMed ID: 27031482
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.
van der Vaart T; Rietman AB; Plasschaert E; Legius E; Elgersma Y; Moll HA;
Neurology; 2016 Jan; 86(2):154-60. PubMed ID: 26519538
[TBL] [Abstract][Full Text] [Related]
17. The impact of ADHD on the cognitive and academic functioning of children with NF1.
Pride NA; Payne JM; North KN
Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in neurofibromatosis type 1.
Ozonoff S
Am J Med Genet; 1999 Mar; 89(1):45-52. PubMed ID: 10469436
[TBL] [Abstract][Full Text] [Related]
19. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.
Descheemaeker MJ; Ghesquière P; Symons H; Fryns JP; Legius E
J Intellect Disabil Res; 2005 Jan; 49(Pt 1):33-46. PubMed ID: 15634310
[TBL] [Abstract][Full Text] [Related]
20. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.
Hyman SL; Arthur Shores E; North KN
Dev Med Child Neurol; 2006 Dec; 48(12):973-7. PubMed ID: 17109785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
